At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Theraworx Foam on Pain and Motion and Patient-Reported Outcomes in Thumb Arthritis
In Brief
A Phase 3 clinical trial evaluating Theraworx and Placebo for Arthritis. Completed, enrolled 40 participants across 3 sites.
Detailed Summary
Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40, which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are both conservative and surgical with surgical options including osteotomy, bone excision, ligament reconstruction, and various prosthetic implants. The conservative treatment options, however, are limited to NSAIDs and bracing or steroid injections. Advances in topical therapies have the potential to deliver focused treatment to the CMC joint. Novel treatment of inflammation can potentially reduce inflammation and pain associated with progressing osteoarthritis. Theraworx Relief is an FDA registered foam that has theoretical impact on inflammation reduction in human subjects treated with the topical foam.
Study Details
Timeline
Interventions
Theraworx foam applied to skin and/or compression wrap
Placebo foam